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INTRODUCTION
Patent foramen ovale (PFO) is a common abnormal-
ity of fetal origin causing right-to-left shunts which 
are associated with a variety of severe pathological 
processes like cryptogenic stroke, vein-to-artery gas 
embolism associated with decompression sickness in 
divers and even systemic hypoxemia1. 
Diagnosis of PFO is achieved mainly with echo-
cardiographic techniques like TransThoracic Echocar-
diography (TTE) and TransEsophageal Echocardiog-
raphy (TEE), while TransCranial Doppler (TCD) is 
another method commonly used. Among them TTE is 
of limited diagnostic power, while TEE is considered 
the golden standard for detection of PFO2. Unfortu-
nately, TEE is a semi-invasive, unpleasant procedure 
for a patient that requires mild sedation3. On the con-
trary, TCD is an easy-to-perform, non-invasive tech-
nique4, simple and friendly to the patient. Moreover 
there is an ongoing effort to associate the findings on 
TCD, with the presence and the size of PFO. Gener-
ally, TCD is considered a reliable technique for diag-
nosis of PFO5-8, even though there are some objections 
on its accuracy9 and is therefore of limited use10. Yet, 
there is only a small number of studies investigating 
the association between microembolic (HITS) signals 
on TCD and the size of PFO11-13 with controversial re-
sults. 
This study was designed to investigate the correla-
tion between the presence and size of PFO with the 
findings of TCD in healthy volunteers and patients 
with ischemic stroke or other pathological conditions 
associated with right-to-left shunt.
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PATIENTS AND METHODS
Patients 
The study group was comprised of 103 individuals, 
61 males and 42 females (age 15 to 81 years), healthy 
volunteers (60), and patients with ischemic stroke or 
other cerebrovascular diseases (43), with or without a 
history of PFO. In all subjects TCD was performed as 
part of the diagnostic process. The presence of PFO as 
well as its size were recorded from the medical history 
of the patient or evaluated with TEE after the TCD 
examination if possible. Patients with microemboli 
detected on TCD and PFO were classified according 
to age into two groups (< 45years and ≥ 45years). 
The study was approved by the Bioethics and De-
ontology Committee of the Medicine School of Aris-
totle University of Thessaloniki, Greece.
TCD
TCD was performed with the patient in a supine posi-
tion. The equipment used was a Multi-Dop T (DWL, 
Germany) device with 2 MHz probes. Bilateral middle 
cerebral arteries (MCA) were insonated through the 
temporal window at a depth of 50 to 60 mm. Contrast 
consisted of 10 ml air-mixed saline solution, (9 ml of 
normal saline solution and 1 ml of air), injected as a 
bolus twice into a large right antecubital vein, while 
resting and before Valsalva maneuver (VM). The VM 
was performed five seconds after intravenous contrast 
injection. A right-to-left shunt was considered posi-
tive when at least one High Intensity Transient Signal 
(HITS) was recorded between 5 and 20 seconds af-
ter the injection of contrast. Only HITS of amplitude 
> = 12dB were recorded for both MCAs. For each pa-
tient the time required for the first HITS to appear, 
the number of HITS, and the mean HITS amplitude 
were estimated after the examination from the record 
file using monitor software MF (DWL Elektronisch 
Systeme GmbH) ver. 8.27.
TEE
ΤΕΕ was performed under local anesthesia. A Philips 
iE33 xMATRIX Echocardiography System, 3D/2D 
(Philips Healthcare, Hamburg, Germany) was used. 
The size of PFO was measured by 2D TEE mode as 
maximal diameter of PFO defect. 
STATISTICAL ANALYSIS
The relationship between the size of PFO on TEE and 
the various parameters recorded on TCD were evalu-
ated with Spearman’s correlation coefficiency (rs). All 
statistical tests were two-tailed and level of signifi-
cance was set at p < 0.05. Student’s t-test was applied 
for means comparison. Data were analyzed using 
SPSS ver.18 for windows.
RESULTS 
Transcranial Doppler examination revealed the pres-
ence of HITS in 47 of 103 subjects. Only 3 patients 
with diagnosed PFO were not identified with TCD. In 
4 patients without PFO, as shown in TEE, a relatively 
small number of HITS (7-14) were recorded only af-
ter VM. Finally in 5 patients with HITS on TCD it 
was not possible to identify the presence of PFO due 
to lack of TEE data. The comparison of TCD versus 
TEE results are indicated in Table 1. PFO diagnosis as 
presence of HITS on TCD had a 92.68% sensibility, 
89.47% specificity, 86.65% positive predictive value 
and 94.44% negative predictive value. 
Among the 38 individuals with PFO and HITS on 
TCD, 22 gave HITS without VM, while in 16 the per-
formance of VM was necessary for HITS to appear. 
The size of PFO was evenly distributed between the 
two groups (Kolmogorov-Smirnov Test, p > 0,751).
The maximum diameter of PFO was measured 
with TEE to 31 individuals (15 males and 16 fe-
males). There was a statistically significant moderate 
correlation between the maximum diameter of PFO 
and the number of HITS after the Valsalva maneuver 
(rs = 0.404, p = 0.026) while there was no correlation 
between the maximum diameter of PFO and gender 
(p = 0.428), age (p = 0.795), first HITS time 
(p = 0.693) or mean amplitude of HITS (p = 0.121). 
Table 1. TCD versus TEE for PFO identification. 
(+: presence of PFO, -: absence of PFO).
TEE+ TEE- Total
TCD+ 38 6 44
TCD- 3 51 54
Total 41 57 98
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Further analysis for gender (Figure 1) shown that 
there was no correlation between the maximum di-
ameter of PFO and the number of HITS in women 
(p = 0.920), while there was a strong correlation in 
men (rs = 0.781, p = 0.003). Only in men, the number 
of HITS was also correlated moderately with the time 
of first HITS (rs = -0.565, p = 0.013). Another differ-
ence between genders observed, was that the average 
time for the fist HITS is shorter for women (t = 2.114, 
p = 0,041). This difference was more clear for young 
patients (age < 45) (p = 0.009) while there was no 
difference in patients older than 45 years (p = 0.685).
The group of healthy volunteers, consisted of 60 
individuals. None of these subjects had a history of 
PFO, but 4 of them (5%) presented HITS on TCD. A 
TEE was performed for 1 of these subjects and it was 
positive for PFO, but no TEE was available or pos-
sible to perform on the remainder 3 of them in order 
to reach a definite diagnosis. In total, 47 subjects out 
of the 103 (45.63%), 22 males and 25 females, were 
found positive for HITS on TCD; of them 38 (80.85%) 
had a positive diagnosis of a PFO, 4 (8.5%) were 
found negative for PFO on TEE, 2 (4.25 %) had other 
heart defects producing a right-to left shunt, while on 
3 individuals (6.12%) there was no information on the 
presence or absence of PFO or other related disorders.
DISCUSSION
In our study 41 individuals out of a sample of 103 
subjects (39.8%) presented with a PFO, a percentage 
which appears to be higher than the incidence of PFO 
in the general population (27%)1. This can be attribut-
ed to the fact that a high percentage of our sample (43 
subjects – 41,7%) were patients suffering from cere-
brovascular disease, given the theory that PFO could 
contribute to this condition.
Our results indicated that TCD is a good predic-
tor of PFO both in terms of sensibility and specificity. 
A recent retrospective study of 45 patients for PFO 
screening14 gave very similar percentages of sensibil-
ity (92.84%) and specificity (82.35%) between TEE 
and TCD, while the general accepted values15 are be-
tween 90% and 95% although it can vary16. Other tran-
scranial sonographic methods gave similar results17. 
Although in the literature the diagnosis of PFO 
with TCD is considered a generally accepted meth-
od18-19, the data on the correlation between the micro-
embolic signals on TCD and the size of PFO are very 
limited11. In our study a significant correlation was 
found between PFO size measured by 2D TEE and 
the number of HITS detected on TCD but this cor-
relation is gender biased as female patients shown no 
Figure 1. Scatter plot of number of HITS on TCD with VM versus PFO size recorded on TEE. 
(black dots = men, grey dots = women).
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correlation between the size of PFO and the number 
of HITS counted.
Telma et al.11, also found a significant correlation 
between the size of PFO on TEE and the number of 
microembolic signals detected on TCD. One limita-
tion in their work was the semi-quantitative nature of 
their data (the exact size of PFO was not known in all 
patients); a problem absent in our study. Telman12 in 
his response to the criticism of Sharma13 implies that 
gender may be a critical factor in PFO studies, with 
no further elaboration. Other studies20 noticed the ef-
fect of gender on the association of PFO with embolic 
signals on TCD, revealing the need for additional re-
search on the reasons behind these gender related dif-
ferences. 
Transcranial Doppler studies21-22 have shown a sex-
depended hemispheric difference in mean flow veloc-
ity in the left middle cerebral artery, and changes of 
cerebrovascular reactivity associated with menopause 
and the protective role of oestrogens on the vascular 
system. In any case no clear aetiology is given up to 
date and therefore further anatom-o-physiological 
studies are required.
List of abbreviations
PFO: Patent Foramen Ovale
TEE: TransEsophageal Echocardiography
TCD: TransCranial Doppler
HITS: High Intensity Transient Signal
ΠΕΡΙΛΗΨΗ: Το ενδιαφέρον για τη χρήση των ευρημάτων του διακρανιακού Doppler (TCD) ως μιας διαγνωστικής τεχνι-
κής για τον καθορισμό της παρουσίας ανοιχτού ωοειδούς τρήματος (PFO) είναι συνεχώς αυξανόμενο. Σκοπός αυτής της 
μελέτης είναι η διερεύνηση της ευαισθησίας του TCD για την ανίχνευση της παρουσίας PFO και η συσχέτιση του μεγέθους 
του PFO με τα μικροέμβολα που ανιχνεύονται. Η ομάδα μελέτης περιελάμβανε 103 άτομα, υγιείς εθελοντές και ασθενείς 
με ισχαιμικά εγκεφαλικά επεισόδια ή άλλες αγγειακές εγκεφαλικές νόσους. Σε όλα τα άτομα πραγματοποιήθηκε TCD, ενώ 
η παρουσία και το μέγεθος του PFO εκτιμηθήκαν με διοισοφάγειο υπερηχοκαδιογράφημα (ΤΤΕ). Η διάγνωση του PFO από 
τα δεδομένα του TCD παρουσίασε 92,68% ευαισθησία, 89,47% ειδικότητα, 86,65% θετική διαγνωστική αξία και 94,44% 
αρνητική διαγνωστική αξία. Το μέγεθος του PFO συσχετίστηκε μέτρια με τον αριθμό των μικροεμβόλων που ανιχνεύονταν 
(rs = 0.404, p = 0.026). Η συσχέτιση των αποτελεσμάτων με το φύλο έδειξε μια ισχυρή συσχέτιση για τους άντρες (rs = 0.781, 
p = 0.003) και έλλειψη συσχέτισης για τις γυναίκες (p = 0.92). Τα αποτελέσματα υποδηλώνουν ότι το TCD έχει καλή προ-
γνωστική αξία για την παρουσία PFO. Η συσχέτιση του μεγέθους του PFO, όπως καταγράφεται με TTE, και του αριθμού 
των μικροεμβόλων που ανιχνεύονται με TCD επηρεάζεται από το φύλο. Η κατανόηση αυτής της διαφοροποίησης απαιτεί 
επιπρόσθετες ανατομικο-φυσιολογικές μελέτες.
Λέξεις Κλειδιά: Ανοικτό ωοειδές τρήμα, Ενδοκράνιο, Ενδοκρανιακό, υπερηχογράφημα, Υπερηχογραφία, Doppler.
Εκτίμηση ανοικτού ωοειδούς τρήματος με τη χρήση του ενδοκράνιου Doppler. 
Υπάρχει συσχέτιση με το φύλο του εξεταζομένου;
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